Bone marrow-derived CD133+ cells

CD133+ cell therapy · Royan Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bone marrow-derived CD133+ cells, covering 2013-08-28 to 2013-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head [Phase 1]